AstraZeneca is a global biopharmaceutical company recognized for groundbreaking treatments in oncology, cardiovascular, and respiratory diseases.
Its oncology division leads in hormone-dependent cancer therapy with Goserelin (Zoladex), used for managing prostate cancer, breast cancer, and endometriosis.
Zoladex is trusted by oncologists worldwide for its proven ability to suppress hormone production and slow tumor growth.
AstraZeneca continues to pioneer targeted and immuno-oncology therapies to improve long-term cancer outcomes.